AC
TAK icon

Asio Capital’s Takeda Pharmaceutical TAK Stock Holding History

Asio Capital’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-103,665
Closed -$1.85M – 86
2020
Q3 		$1.85M Buy
103,665
+7,535
+8% +$137K 1.01% 49
2020
Q2 		$1.72M Buy
96,130
+6,870
+8% +$123K 1.09% 47
2020
Q1 		$1.35M Buy
89,260
+6,223
+7% +$113K 1.16% 43
2019
Q4 		$1.64M Buy
+83,037
New +$1.59M 0.85% 40

Other funds holding TAK

GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Asio Capital's TAK Position: Q4 2020 in Review

Asio Capital sold out of Takeda Pharmaceutical (TAK) in Q4 2020, closing a stake of 103,665 shares — an estimated $1.85M sold.

Asio Capital first reported a position in TAK in Q4 2019 and held it in 4 quarters. The position peaked at $1.85M in Q3 2020. 313 funds tracked by Wall St. Rank hold TAK as of Q4 2020.

  • Asio Capital reported no remaining Takeda Pharmaceutical position as of Q4 2020 after selling out during the quarter.
  • Asio Capital sold 103,665 Takeda Pharmaceutical shares in Q4 2020, an estimated $1.85M.
  • Asio Capital first reported a position in Takeda Pharmaceutical in Q4 2019 and held it in 4 quarters.
  • Asio Capital's Takeda Pharmaceutical position peaked at $1.85M in Q3 2020.
  • 313 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2020.

Based on Asio Capital's 13F filing for Q4 2020, filed 8 Feb 2021.